KKR & Co. Inc. (NYSE:KKR) Price Target Raised to $184.00 at TD Cowen

KKR & Co. Inc. (NYSE:KKR) had its price target lifted by TD Cowen from $166.00 to $184.00 in a research note issued to investors on Friday morning, Benzinga reports. They currently have a buy rating on the asset manager’s stock.

KKR has been the topic of a number of other reports. Morgan Stanley boosted their target price on KKR & Co. Inc. from $107.00 to $143.00 and gave the stock an “equal weight” rating in a research report on Thursday, October 10th. Evercore ISI boosted their price objective on shares of KKR & Co. Inc. from $135.00 to $145.00 and gave the stock an “outperform” rating in a research report on Monday, October 14th. Hsbc Global Res upgraded shares of KKR & Co. Inc. to a “strong-buy” rating in a report on Wednesday, September 18th. Argus upgraded shares of KKR & Co. Inc. to a “strong-buy” rating in a research report on Thursday, August 1st. Finally, Deutsche Bank Aktiengesellschaft increased their price target on shares of KKR & Co. Inc. from $128.00 to $141.00 and gave the company a “buy” rating in a research report on Thursday, August 1st. One equities research analyst has rated the stock with a sell rating, two have given a hold rating, twelve have issued a buy rating and two have given a strong buy rating to the stock. Based on data from MarketBeat, the stock currently has a consensus rating of “Moderate Buy” and an average price target of $151.29.

KKR & Co. Inc. Stock Down 2.4 %

Shares of NYSE KKR opened at $139.88 on Friday. The company has a quick ratio of 0.07, a current ratio of 0.07 and a debt-to-equity ratio of 0.86. KKR & Co. Inc. has a 52 week low of $53.72 and a 52 week high of $147.15. The firm has a 50-day moving average price of $128.49 and a 200 day moving average price of $114.09. The stock has a market capitalization of $124.14 billion, a price-to-earnings ratio of 32.99, a price-to-earnings-growth ratio of 1.20 and a beta of 1.62.

KKR & Co. Inc. (NYSE:KKR) last issued its earnings results on Thursday, October 24th. The asset manager reported $1.38 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.03 by $0.35. The company had revenue of $4.79 billion during the quarter, compared to analysts’ expectations of $1.23 billion. KKR & Co. Inc. had a net margin of 17.99% and a return on equity of 5.05%. During the same period last year, the company posted $0.73 earnings per share. Equities research analysts anticipate that KKR & Co. Inc. will post 3.97 EPS for the current fiscal year.

KKR & Co. Inc. Dividend Announcement

The firm also recently announced a quarterly dividend, which will be paid on Tuesday, November 19th. Investors of record on Monday, November 4th will be given a dividend of $0.175 per share. The ex-dividend date of this dividend is Monday, November 4th. This represents a $0.70 annualized dividend and a yield of 0.50%. KKR & Co. Inc.’s dividend payout ratio (DPR) is presently 16.51%.

Insiders Place Their Bets

In other news, major shareholder Genetic Disorder L.P. Kkr sold 5,800,000 shares of the stock in a transaction dated Friday, September 13th. The shares were sold at an average price of $25.75, for a total transaction of $149,350,000.00. Following the transaction, the insider now directly owns 25,260,971 shares in the company, valued at $650,470,003.25. This represents a 0.00 % decrease in their position. The sale was disclosed in a legal filing with the SEC, which is available at this link. In other news, major shareholder Kkr Group Partnership L.P. bought 11,619,998 shares of KKR & Co. Inc. stock in a transaction that occurred on Wednesday, September 11th. The shares were purchased at an average price of $11.13 per share, for a total transaction of $129,330,577.74. Following the completion of the acquisition, the insider now owns 92,959,984 shares of the company’s stock, valued at $1,034,644,621.92. The trade was a 0.00 % increase in their ownership of the stock. The acquisition was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. Also, major shareholder Genetic Disorder L.P. Kkr sold 5,800,000 shares of the firm’s stock in a transaction dated Friday, September 13th. The stock was sold at an average price of $25.75, for a total value of $149,350,000.00. Following the completion of the transaction, the insider now owns 25,260,971 shares in the company, valued at approximately $650,470,003.25. This trade represents a 0.00 % decrease in their ownership of the stock. The disclosure for this sale can be found here. 39.34% of the stock is owned by corporate insiders.

Hedge Funds Weigh In On KKR & Co. Inc.

Several hedge funds and other institutional investors have recently modified their holdings of KKR. Versant Capital Management Inc lifted its position in KKR & Co. Inc. by 622.9% during the second quarter. Versant Capital Management Inc now owns 253 shares of the asset manager’s stock valued at $27,000 after buying an additional 218 shares in the last quarter. Mather Group LLC. raised its stake in shares of KKR & Co. Inc. by 371.4% in the 2nd quarter. Mather Group LLC. now owns 264 shares of the asset manager’s stock valued at $27,000 after acquiring an additional 208 shares during the period. ORG Wealth Partners LLC purchased a new position in shares of KKR & Co. Inc. in the 3rd quarter valued at $31,000. Raleigh Capital Management Inc. lifted its holdings in shares of KKR & Co. Inc. by 56.7% during the 3rd quarter. Raleigh Capital Management Inc. now owns 235 shares of the asset manager’s stock valued at $31,000 after acquiring an additional 85 shares in the last quarter. Finally, Eastern Bank acquired a new position in shares of KKR & Co. Inc. during the 3rd quarter valued at $34,000. 76.26% of the stock is owned by institutional investors and hedge funds.

About KKR & Co. Inc.

KKR & Co Inc is a private equity and real estate investment firm specializing in direct and fund of fund investments. It specializes in acquisitions, leveraged buyouts, management buyouts, credit special situations, growth equity, mature, mezzanine, distressed, turnaround, lower middle market and middle market investments.